Abstraction Health

DHEA — Research Evidence

Source: PubMed / NCBI · human studies preferred · ranked by evidence qualityLast analyzed: May 24, 2026
🔵Mixed Evidence
20 studies·2 RCTs·16 reviews

The summary below was generated by an AI system (Claude) based on the studies listed. It is a synthesis tool, not a clinical opinion. Read individual studies for full context.

The research base for DHEA supplementation is broad but uneven in quality. The available literature — spanning reviews, one RCT, a systematic review, and a meta-analysis — consistently establishes DHEA's physiological role as a precursor to both androgens (including testosterone) and estrogens, produced primarily by the adrenal glands. DHEA-S levels are well-documented to decline substantially with age, a phenomenon sometimes called 'adrenopause,' which has motivated interest in supplementation for older adults. However, despite this mechanistic rationale, the clinical evidence for most proposed benefits remains sparse, with the majority of expert claims in this domain rated as having insufficient evidence.

Key findings

  • DHEA is produced primarily by the adrenal glands and is the most abundant steroid hormone precursor in the body, converting downstream into both androgens and estrogens — this role is well-established across multiple reviews.
  • DHEA-S levels decline significantly with age ('adrenopause'), providing a physiological rationale for supplementation in older adults, though clinical benefit from restoring levels has not been robustly demonstrated.
  • A meta-analysis of placebo-controlled RCTs suggests DHEA supplementation may have a modest effect on bone mineral density in healthy adults, but the clinical significance is unclear.
  • A systematic review found limited and inconsistent evidence that 7-keto-DHEA (a non-hormonal metabolite) supports body weight reduction.
  • Theoretical concerns about DHEA supplementation in people at risk for hormone-sensitive cancers (e.g., prostate or breast cancer) are acknowledged in the literature and have not been adequately resolved.

Evidence gaps

  • ?There is a lack of large, high-quality RCTs directly testing DHEA supplementation across its most commonly claimed benefits — including cognitive function, mood, libido, muscle mass, and longevity — leaving the majority of expert claims unsupported by direct trial evidence.
  • ?Long-term safety data for DHEA supplementation, particularly regarding hormone-sensitive cancer risk and cardiovascular effects, are insufficient to draw firm conclusions.
  • ?The optimal dosing range, target populations, and monitoring protocols for DHEA supplementation (e.g., trialing 25–50 mg/day in low-DHEA-S adults over 50) have not been systematically validated in clinical trials.

Safety summary

DHEA is generally described as well-tolerated at low-to-moderate doses in short-term studies, but its conversion to androgens and estrogens raises theoretical concerns about hormone-sensitive cancers and androgenic side effects (e.g., acne, hair loss, virilization in women) that have not been fully characterized in long-term research. Caution is warranted in individuals with or at risk for hormone-sensitive conditions.

Studies (20)

A systematic review and meta-analysis of randomized placebo-controlled trials of DHEA supplementation of bone mineral density in healthy adults.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology · 2019 · Lin H et al.
Meta-Analysis🟢
Key finding

A systematic review and meta-analysis of randomized placebo-controlled trials of DHEA supplementation of bone mineral density in healthy adults.

PMID: 31237150DOI: 10.1080/09513590.2019.1616175
View on PubMed

Effects of dehydroepiandrosterone (DHEA) supplementation on the lipid profile: A systematic review and dose-response meta-analysis of randomized controlled trials.

Nutrition, metabolism, and cardiovascular diseases : NMCD · 2020 · Qin Y et al.
Meta-Analysis🟢
Key finding

Effects of dehydroepiandrosterone (DHEA) supplementation on the lipid profile: A systematic review and dose-response meta-analysis of randomized controlled trials.

COI: Declaration of Competing Interest The authors declare no conflict of interest.
PMID: 32675010DOI: 10.1016/j.numecd.2020.05.015
View on PubMed

A systematic review of the impact of 7-keto-DHEA on body weight.

Archives of gynecology and obstetrics · 2023 · Jeyaprakash N et al.
Systematic Review🟢
Key finding

A systematic review of the impact of 7-keto-DHEA on body weight.

COI: The authors have no conflicts of interest to declare.
PMID: 36566478DOI: 10.1007/s00404-022-06884-8
View on PubMed

Vitamin C supplementation alleviates hypercortisolemia caused by chronic stress.

Stress and health : journal of the International Society for the Investigation of Stress · 2024 · Beglaryan N et al.
RCT🟡
Key finding

Vitamin C supplementation alleviates hypercortisolemia caused by chronic stress.

PMID: 38010274DOI: 10.1002/smi.3347
View on PubMed

An investigation into the stress-relieving and pharmacological actions of an ashwagandha (Withania somnifera) extract: A randomized, double-blind, placebo-controlled study.

Medicine · 2019 · Lopresti AL et al.
RCT🟡
Key finding

An investigation into the stress-relieving and pharmacological actions of an ashwagandha (Withania somnifera) extract: A randomized, double-blind, placebo-controlled study.

COI: This study was independently managed by the principal investigators, Dr HM and RK, who declare no competing interests. Dr AL has received study funding from Arjuna Natural Extracts Ltd in the past for previously completed unrelated studies and has received compensation for conference presentations. The authors have no conflicts of interest to disclose.
PMID: 31517876DOI: 10.1097/MD.0000000000017186
View on PubMed

Vitamin D in Prostate Cancer.

Vitamins and hormones · 2016 · Ahn J et al.
Review🟡
Key finding

Vitamin D in Prostate Cancer.

Funded by: BLRD VA, NCI NIH HHS, NIA NIH HHS
PMID: 26827958DOI: 10.1016/bs.vh.2015.10.012
View on PubMed

Testosterone prohormone supplements.

Medicine and science in sports and exercise · 2006 · Brown GA et al.
Review🟡
Key finding

Testosterone prohormone supplements.

PMID: 16888459DOI: 10.1249/01.mss.0000228928.69512.2e
View on PubMed

Nutritional supplements and IVF: an evidence-based approach.

Reproductive biomedicine online · 2024 · Hart RJ
Review🟡
Key finding

Nutritional supplements and IVF: an evidence-based approach.

PMID: 38184959DOI: 10.1016/j.rbmo.2023.103770
View on PubMed

Dehydroepiandrosterone (DHEA): Pharmacological Effects and Potential Therapeutic Application.

Mini reviews in medicinal chemistry · 2023 · Nenezic N et al.
Review🟡
Key finding

Dehydroepiandrosterone (DHEA): Pharmacological Effects and Potential Therapeutic Application.

Funded by: Industry (inferred from affiliations)
PMID: 36121077DOI: 10.2174/1389557522666220919125817
View on PubMed

Androgens and antiandrogens.

Annals of the New York Academy of Sciences · 2003 · Schneider HP
Review🟡
Key finding

Androgens and antiandrogens.

PMID: 14644837DOI: 10.1196/annals.1290.033
View on PubMed

Sarcopenia and aging.

Nutrition reviews · 2003 · Kamel HK
Review🟡
Key finding

Sarcopenia and aging.

PMID: 12822704DOI: 10.1301/nr.2003.may.157-167
View on PubMed

Androgens in women.

The Journal of steroid biochemistry and molecular biology · 2003 · Davison SL et al.
Review🟡
Key finding

Androgens in women.

PMID: 12943723DOI: 10.1016/s0960-0760(03)00204-8
View on PubMed

[Adrenopause].

Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego · 2008 · Szkróbka W et al.
Review🟡
Key finding

[Adrenopause].

Funded by: Industry (inferred from affiliations)
PMID: 18839621
View on PubMed

DHEA, physical exercise and doping.

The Journal of steroid biochemistry and molecular biology · 2015 · Collomp K et al.
Review🟡
Key finding

DHEA, physical exercise and doping.

Funded by: Industry (inferred from affiliations)
PMID: 24704255DOI: 10.1016/j.jsbmb.2014.03.005
View on PubMed

Dehydroepiandrosterone (DHEA): hypes and hopes.

Drugs · 2014 · Rutkowski K et al.
Review🟡
Key finding

Dehydroepiandrosterone (DHEA): hypes and hopes.

PMID: 25022952DOI: 10.1007/s40265-014-0259-8
View on PubMed

DHEA treatment: myth or reality?

Trends in endocrinology and metabolism: TEM · 2002 · Allolio B et al.
Review🟡
Key finding

DHEA treatment: myth or reality?

PMID: 12163230DOI: 10.1016/s1043-2760(02)00617-3
View on PubMed

Dehydroepiandrosterone Research: Past, Current, and Future.

Vitamins and hormones · 2018 · Klinge CM et al.
Review🟡
Key finding

Dehydroepiandrosterone Research: Past, Current, and Future.

PMID: 30029723DOI: 10.1016/bs.vh.2018.02.002
View on PubMed

Dehydroepiandrosterone (DHEA) supplementation and IVF outcome in poor responders.

Human fertility (Cambridge, England) · 2017 · Triantafyllidou O et al.
Review🟡
Key finding

Dehydroepiandrosterone (DHEA) supplementation and IVF outcome in poor responders.

PMID: 27927044DOI: 10.1080/14647273.2016.1262065
View on PubMed

The role for long-term use of dehydroepiandrosterone in adrenal insufficiency.

Current opinion in endocrinology, diabetes, and obesity · 2022 · Bennett G et al.
Review🟡
Key finding

The role for long-term use of dehydroepiandrosterone in adrenal insufficiency.

PMID: 35621180DOI: 10.1097/MED.0000000000000728
View on PubMed

Effect of Dehydroepiandrosterone (DHEA) on Diabetes Mellitus and Obesity.

Vitamins and hormones · 2018 · Aoki K et al.
Review🟡
Key finding

Effect of Dehydroepiandrosterone (DHEA) on Diabetes Mellitus and Obesity.

PMID: 30029734DOI: 10.1016/bs.vh.2018.01.008
View on PubMed